Showing results (351-360 of 1,068) with videos related to
Sort By:
Pageof 107
Journal of Pharmacokinetics and Pharmacodynamics|December 24, 2011
Multi-response model for rheumatoid arthritis based on delay differential equations in collagen-induced arthritic mice treated with an anti-GM-CSF antibodyGilbert Koch, Thomas Wagner, Christine Plater-Zyberk, et al.Journal of Pharmacokinetics and Pharmacodynamics|December 14, 2011
BioDMET: a physiologically based pharmacokinetic simulation tool for assessing proposed solutions to complex biological problemsJohn F Graf, Bernhard J Scholz, Maria I ZavodszkyJournal of Pharmacokinetics and Pharmacodynamics|May 1, 2012
Analysis of exposure-response of CI-945 in patients with epilepsy: application of novel mixed hidden Markov modeling methodologyMaud Delattre, Radojka M Savic, Raymond Miller, et al.Journal of Pharmacokinetics and Pharmacodynamics|February 22, 2012
Moxifloxacin versus placebo modeling of the QT intervalPhilippe Grosjean, Saïk UrienJournal of Pharmacokinetics and Pharmacodynamics|February 8, 2012
First dose in children: physiological insights into pharmacokinetic scaling approaches and their implications in paediatric drug developmentAshley Strougo, Thomas Eissing, Ashraf Yassen, et al.Journal of Pharmacokinetics and Pharmacodynamics|April 25, 2012
A pharmacokinetic model for the glycation of albuminOskar Alskär, Julia Korell, Stephen B DuffullJournal of Pharmacokinetics and Pharmacodynamics|August 18, 2011
A Bayesian hierarchical nonlinear mixture model in the presence of artifactual outliers in a population pharmacokinetic studyLeena Choi, Brian S Caffo, Utkarsh Kohli, et al.Journal of Pharmacokinetics and Pharmacodynamics|September 13, 2011
A hidden Markov model to assess drug-induced sleep fragmentation in the telemetered ratC Diack, O Ackaert, B A Ploeger, et al.Journal of Pharmacokinetics and Pharmacodynamics|August 25, 2011
Allometric scaling of pegylated liposomal anticancer drugsWhitney P Caron, Harvey Clewell, Robert Dedrick, et al.Journal of Pharmacokinetics and Pharmacodynamics|September 8, 2011
Evaluation of false positive rate based on exposure-response analyses for two compounds in fixed-dose combination productsHao Zhu, Yaning WangPageof 107